These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 29122547)
1. Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer. Spence AD; Busby J; Johnston BT; Baron JA; Hughes CM; Coleman HG; Cardwell CR Gastroenterology; 2018 Mar; 154(4):849-860.e1. PubMed ID: 29122547 [TBL] [Abstract][Full Text] [Related]
2. Statin use and survival in patients with gastric cancer in two independent population-based cohorts. Spence AD; Busby J; Hughes CM; Johnston BT; Coleman HG; Cardwell CR Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):460-470. PubMed ID: 30456916 [TBL] [Abstract][Full Text] [Related]
3. Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network. García Rodríguez LA; Soriano-Gabarró M; Vora P; Cea Soriano L Int J Cancer; 2020 Nov; 147(9):2394-2404. PubMed ID: 32329063 [TBL] [Abstract][Full Text] [Related]
4. Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study. Liu P; McMenamin ÚC; Spence AD; Johnston BT; Coleman HG; Cardwell CR BMC Cancer; 2019 Oct; 19(1):1017. PubMed ID: 31664951 [TBL] [Abstract][Full Text] [Related]
5. Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis. Lin JL; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Huang CM BMC Cancer; 2020 Jul; 20(1):638. PubMed ID: 32646396 [TBL] [Abstract][Full Text] [Related]
6. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. Bhat S; Coleman HG; Yousef F; Johnston BT; McManus DT; Gavin AT; Murray LJ J Natl Cancer Inst; 2011 Jul; 103(13):1049-57. PubMed ID: 21680910 [TBL] [Abstract][Full Text] [Related]
7. Exposure to oral bisphosphonates and risk of esophageal cancer. Cardwell CR; Abnet CC; Cantwell MM; Murray LJ JAMA; 2010 Aug; 304(6):657-63. PubMed ID: 20699457 [TBL] [Abstract][Full Text] [Related]
8. Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients. Ayyagari S; Tan MC; Liu Y; El-Serag HB; Thrift AP Dig Dis Sci; 2020 Sep; 65(9):2691-2699. PubMed ID: 31802383 [TBL] [Abstract][Full Text] [Related]
9. Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study. Mc Menamin ÚC; Cardwell CR; Hughes CM; Murray LJ Cancer Epidemiol; 2017 Apr; 47():20-27. PubMed ID: 28088656 [TBL] [Abstract][Full Text] [Related]
10. Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study. Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Dalton SO; Nørgaard M; Pottegård A; Hallas J; Sørensen HT; Friis S Ann Intern Med; 2019 Apr; 170(7):443-452. PubMed ID: 30831581 [TBL] [Abstract][Full Text] [Related]
11. Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer. Macfarlane TV; Murchie P; Watson MC Cancer Epidemiol; 2015 Dec; 39(6):1015-22. PubMed ID: 26590503 [TBL] [Abstract][Full Text] [Related]
12. Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: A Population-Based Cohort Study. Alexandre L; Clark AB; Bhutta HY; Chan SS; Lewis MP; Hart AR Gastroenterology; 2016 Apr; 150(4):854-65.e1; quiz e16-7. PubMed ID: 26775632 [TBL] [Abstract][Full Text] [Related]
13. Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort. Cardwell CR; Kunzmann AT; Cantwell MM; Hughes C; Baron JA; Powe DG; Murray LJ Gastroenterology; 2014 Mar; 146(3):700-708.e2. PubMed ID: 24239563 [TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and esophageal and gastric cancer. Lin Y; Ness-Jensen E; Hveem K; Lagergren J; Lu Y Cancer Causes Control; 2015 Dec; 26(12):1825-34. PubMed ID: 26450604 [TBL] [Abstract][Full Text] [Related]
15. Low-dose aspirin use and endometrial cancer mortality-a Danish nationwide cohort study. Sperling CD; Verdoodt F; Aalborg GL; Dehlendorff C; Friis S; Kjaer SK Int J Epidemiol; 2020 Feb; 49(1):330-337. PubMed ID: 31845990 [TBL] [Abstract][Full Text] [Related]
16. Statin use and breast cancer survival: a nationwide cohort study in Scotland. Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR BMC Cancer; 2016 Aug; 16():600. PubMed ID: 27491389 [TBL] [Abstract][Full Text] [Related]
17. Cumulative Dose Threshold for the Chemopreventive Effect of Aspirin Against Gastric Cancer. Kim MH; Chang J; Kim WJ; Banerjee S; Park SM Am J Gastroenterol; 2018 Jun; 113(6):845-854. PubMed ID: 29855546 [TBL] [Abstract][Full Text] [Related]
18. Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink. Cardwell CR; Flahavan EM; Hughes CM; Coleman HG; O'Sullivan JM; Powe DG; Murray LJ Cancer Causes Control; 2014 Jan; 25(1):33-43. PubMed ID: 24310109 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study. Busby J; McMenamin Ú; Spence A; Johnston BT; Hughes C; Cardwell CR Aliment Pharmacol Ther; 2018 Jan; 47(2):279-288. PubMed ID: 29105106 [TBL] [Abstract][Full Text] [Related]
20. Does low-dose aspirin use for cardiovascular disease prevention reduce colorectal cancer deaths? A comparison of two cohorts in the Florence district, Italy. Ventura L; Miccinesi G; Barchielli A; Manneschi G; Puliti D; Mantellini P; Orso F; Zappa M Eur J Cancer Prev; 2018 Mar; 27(2):134-139. PubMed ID: 27845951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]